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1. Introduction 
Most normal cells have cell surface properties 
different from their transformed or oncogenic ounter- 
parts (reviewed in [l]). While tumor cells will grow 
without being attached to a substratum, most untrans- 
formed cells require a surface to which they can &here 
in order to grow [2,3]. Variations in cell adhesion 
mediated by changes in the cell surface could play a 
determinant role in the regulation of cell growth and 
development as well as in the mechanism of oncogenesis. 
Bromodeoxyuridine (BrdUrd), a thymidine analogue, 
exerts a selective and reversible ffect on specific cellular 
differentiative functions and oncogenic potential 
(reviewed in [4] and [5] ). Although both DNA-linked 
and non-DNA-mediated ffects of BrdUrd have been 
described [4], the mechanism of action of this drug is 
unknown. While much information has been gathered 
on the effects of BrdUrd on DNA structure, much 
less attention has been paid to BrdUrd’s effects on the 
plasma membrane. In order to evaluate quantitatively 
the effect of BrdUrd on the plasma membrane, adhe- 
sivity of mouse melanoma cells was measured as well 
as their electrophoretic mobility and aqueous polymer 
partitioning behavior. The results how that BrdUrd 
treatment greatly increases the adhesivity of these 
cells without changing their electrophoretic mobility. 
Treatment with BrdUrd does, however, change the 
partition ratio of these cells in aqueous two-phase 
dextran-polyethylene glycol suggesting that basic 
alterations of the cell surface have occurred. 
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2. Materials and methods 
Melanoma cells of the B16 line were grown in glass 
culture bottles as previously described [6]. Cultures 
were incubated at 37°C with 5% CO2 and passaged by 
treatment with 0.025% trypsin solution. Bromodeoxy- 
uridine and thymidine solutions were made up in 0.01 
M phosphate buffered saline, pH 7 (PBS) and. 
sterilized by passage through 0.22 PM Millipore filters. 
Solutions were stored at 0°C for no more than 1 month 
with drug concentrations monitored periodically as 
previously described [6]. 
Adhesivity studies were performed two days after 
BrdUrd or TdR (at 3 &ml media) was added. The 
media was removed, cells were washed twice with PBS 
and cultures incubated for varying time periods with 
0.025% trypsin, or 0.20% EDTA in PBS. At specific 
time periods, duplicate cultures were gently rocked 
5 times, and medium and detached cells collected, 
pipetted to disperse aggregates and counted using a 
Coulter model Z, cell counter. 
Determinations of the electrophoretic mobility of 
cells were made as described previously [7]. Cells, 
detached from the monolayer with 0.2% EDTA, 
were electrophoresed in a medium consisting of 0.0145 
M NaCl, 4.5% sorbitol, 0.6 mM NaHCOs, pH 7.2. Each 
determination consisted of 20-30 observations of
mobility with a reversal qf polarity between each 
observation. 
Cells, removed from the monolayer as for electro- 
phoretic mobility measurements, were partitioned in a 
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two-phase aqueous polymer system essentially as 
described by Gersten and Bosmann [8]. The system 
consisted of 5% (w/w) Dextran T 500 (Pharmacia, Lot 
#3936) and 4.0% (w/w) polyethylene glycol (Carbowax 
6000, Union Carbide) dissolved in 0.1 M phosphate 
buffer (pH 6.98) containing 0.05 M NaCl. Cells were 
partitioned in total vol. 10 ml polymer solution which 
was allowed to stand for 1 h at 4’C. The number of 
cells in the total system before partition and the 
number in the top polymer phase after partition were 
determined using a Coulter Counter model ZB equipped 
with 100 pm aperture. Partition ratios were expressed 
as the number of cells in the top phase divided by the 
number of cells in the total system. 
3. Results and discussion 
B16 cells treated with BrdUrd appear to flatten and 
adhere more tightly to the growth support [5,6]. In 
order to quantify their increased adhesivity, the detach- 
ability of the cells was measured after trypsin or EDTA 
solutions were added to remove them. These solutions 
are thought to detach cells by hydrolyzing cell-surface 
adhesive proteins or by complexing cations needed for 
attachment. When cells are treated with these solutions, 
a clear measurable difference in the number of BrdUrd 
treated cells detached in comparison to thymidine 
treated or control cells is found (fig.1). The control 
or thymidine treated cells show >60% detachment 
after 30 min treatment with trypsin or 50% detachment 
after EDTA incubation in contrast to <20% detachment 
respectively for the BrdUrd-treated cells during the 
same time period. These differences persisted when 
lo-fold higher concentrations of trypsin were utilized 
(data not shown). These results clearly show that the 
BrdUrd-treated cells are more difficult to release from 
their growth plate most likely due to an increased 
surface adhesivity equal to 2-3 times of control ceils. 
One property that is often altered between trans- 
formed and non-transformed cells is the charge on the 
cell surface. Transformed and highly oncogenic cells 
have often been found to have a higher surface net 
negative charge than their non-transformed or normal 
counterparts [9]. In order to determine whether BrdUrd 
treatment altered net surface charge the electrophoretic 
mobility of BrdUrd, TdR, or non-treated cells was 




Fig.1. Kinetics of detachment of cells with trypsin and EDTA. 
(A) Cells previously treated with TdR or BrdUrd, 3 pg/ml 
media, for 2 days were removed from the monolayer using 0.025% 
trypsin for varying periods of time and detached cells counted 
in a Coulter Counter as described in Materials and methods. 
Total cell number in control cultures averaged 5 X lo5 
cells/55 cm1 surface area culture bottle. Data represents 
mean of 2 experiments, each performed using duplicate 
bottles. (B) Detachment studies were performed as described 
above using 0.20% EDTA. Control cells (o-o-o), TdR-treated 
(A-A-A), BrdUrd-treated (x-x-x). 
of cells in an electric field. The results, shown in table 
1, show no appreciable change in electrophoretic 
mobility after treatment of cells with BrdUrd. Thus, 
no appreciable change in cell surface charge properties 
is detectable using this method. 
Several studies have shown that increases in cell 
electrophoretic mobility are often accompanied by 
increasing cell partitioning suggesting that surface 
charge can be an important factor in both these 
separations. Several exceptions to this rule have been 
documented, however, such as the increasing partition, 
but not electrophoresis of stored human erythrocytes 
as compared to freshly drawn samples [lo] and the 
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Table 1 
Electrophoretic mobility of cells 
Treatment Electrophoretic mobility &m-l. V-' . s-l. cm) 
June 1977 
None 2.14 r 0.11 
TdR (3 pg/mJ) 2.01 * 0.07 
BrdUrd (3 rg/ml) 2.07 + 0.10 
Experiments were performed as described in the Materials and methods section. 
Values are means f SEM for cells treated for 2 days with BrdUrd or TdR. Each 
mean is a value determined from 60 observations in 3 independent experiments. 
separation of beef erythrocytes having low, inter- 
mediate or high partition ratios, but identical electro- 
phoretic properties [ 111. Since these latter classes of 
cells release differing amounts of sialic acid, the 
authors conclude that the partition method measures 
membrane associated charges buried deeper in the 
membrane than the cell-mobility method which can 
only detect charges present at the point of shear. 
Other evidence also suggests that cell partitioning, but 
not electrophoretic mobility can be affected by 
changes in fatty acid membrane components [ 121. 
In order to determine whether surface alterations 
could be detected by this technique, BrdUrd-treated, 
TdR-treated and control cells, washed twice with PBS, 
were partitioned in the aqueous system described in 
Materials and methods. The data shown in table 2 
indicates that much fewer (about 3/4 as many cells) 
of the BrdUrd-treated cells are able to move into the 
polyethylene-enriched top phase than the TdR treated 
or control cells. When partitioning was carried out in 
higher salt concentrations, (0.07 M) consistent 
differences in partition cells was also found (data not 
Table 2 
Partitioning of cells in dextran-polyethylene glycol system 
Cells Partition ratios % Control 
Untreated 0.358 + .08 100% 
TdR 0.374 f .07 104% 
BrdUrd 0.277 i .06 77.4% 
Cells were partitioned as described in Materials and methods. 
Cells were treated with BrdUrd or TdR at 3 &ml for 2 days. 
The partition ratio is expressed as top phase cell number 
divided by the total system cell number. Each mean (* SE) 
is a value determined from 70 observations in 7 independent 
experiments. 
shown). These data make clear the BrdUrd does alter 
the surface properties of cells and suggests that the 
surface of BrdUrd-treated cells may be physically and/ 
or chemically distinct from control cell populations due 
to an altered topology and possible alterations in 
charged surface groups. 
The mechanism by which BrdUrd blocks both 
differentiation and oncogenicity of melanoma and 
other cells is unknown. It has been shown in several 
systems that BrdUrds block of the induction of 
differentiation and the drug’s suppression of tumor- 
igenicity require incorporation of BrdUrd into the 
cellular DNA [4,5]. Therefore, if BrdUrd exerted its 
effects on differentiation and oncogenicity at some 
step via the outer cell membrane, one likely possibility 
is that incorporation of BrdUrd prevents the synthesis 
of specific classes of membrane proteins required for 
cellular differentiation and/or oncogenicity. These 
surface modifications could alter cellular function in 
at least two ways. First, BrdUrd treatment may alter 
the cell surface so that expression of neoantigens 
(embryonic, viral, or cellular) is allowed leading to 
changes in the treated cells immunogenicity. These 
changes may allow the host’s immune system to more 
effectively attack and destroy BrdUrd-treated cells. 
Secondly, BrdUrd treatment may alter membrane 
properties so that growth of the cells in the host and 
the expression of the differentiated state is prevented. 
Recent work have centered on the possibility that 
membrane alterations may be involved in the control 
of cellular differentiation and malignant transformation 
[ 13,141. Previous work has shown that BrdUrd treat- 
ment alters the synthesis of a putative membrane 
glycoprotein in neuroblastoma cells [ 151 and alters 
the biochemistry of the surface mucopolysaccharide 
coat of melanoma cells [ 161. The coordinated suppres- 
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sion of melanogenesis and tumorigenicity by BrdUrd 
should be useful in determining what role surface macro- 
molecules play in regulating cellular growth, differen- 
tiation and oncogenicity. 
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